American International Group, Inc. Eye Point Pharmaceuticals, Inc. Transaction History

American International Group, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$19.93 - $29.71 $101,662 - $151,550	5,101 Added 38.42%	18,378 $379,000
Q4 2023 Feb 13, 2024	BUY	$5.71 - $24.13 $1,176 - $4,970	206 Added 1.58%	13,277 $306,000
Q3 2023 Nov 13, 2023	BUY	$7.99 - $15.36 $3,707 - $7,127	464 Added 3.68%	13,071 $104,000
Q2 2023 Aug 04, 2023	BUY	$3.03 - $9.0 $51 - $153	17 Added 0.14%	12,607 $109,000
Q1 2023 May 12, 2023	BUY	$2.28 - $5.04 $572 - $1,265	251 Added 2.03%	12,590 $37,000
Q4 2022 Feb 10, 2023	SELL	$2.37 - $7.2 $106 - $324	-45 Reduced 0.36%	12,339 $43,000
Q3 2022 Nov 14, 2022	BUY	$6.96 - $11.12 $1,218 - $1,945	175 Added 1.43%	12,384 $98,000
Q2 2022 Aug 12, 2022	SELL	$7.25 - $12.71 $1,167 - $2,046	-161 Reduced 1.3%	12,209 $96,000
Q1 2022 May 13, 2022	BUY	$8.67 - $14.11 $9,901 - $16,113	1,142 Added 10.17%	12,370 $150,000
Q4 2021 Feb 11, 2022	SELL	$10.18 - $18.4 $3,420 - $6,182	-336 Reduced 2.91%	11,228 $137,000
Q3 2021 Nov 12, 2021	SELL	$7.51 - $11.72 $2,065 - $3,223	-275 Reduced 2.32%	11,564 $120,000
Q2 2021 Aug 13, 2021	BUY	$8.69 - $11.08 $102,880 - $131,176	11,839 New	11,839 $106,000

163

58.2M

224K

1.41M

Ticker EYPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,072,200
Market Cap $272M
Description
EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.